Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age
Open Access
- 1 January 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 36 (1) , 20-23
- https://doi.org/10.1093/clinchem/36.1.20
Abstract
We quantified lipoprotein(a) [Lp(a)] immunochemically in young (less than 46 y) male survivors of myocardial infarction and in age-matched controls recruited from participants of the Prospective Cardiovascular Münster (PROCAM) study. We further determined apolipoprotein E polymorphism and measured triglycerides, total cholesterol, high- and low-density lipoprotein cholesterol (HDL and LDL), and apolipoproteins AI, AII, and B in the serum of these subjects. Lp(a) concentrations in serum were not correlated with other well-recognized risk factors for early myocardial infarction such as apolipoproteins AI and B, LDL cholesterol, and HDL cholesterol. Apolipoprotein E polymorphism did not affect Lp(a) concentrations, but had a major influence on apolipoprotein B concentration. Lp(a) concentrations were not influenced by age. Our data suggest that (a) an increased concentration of Lp(a) constitutes an independent risk factor for early myocardial infarction and (b) the concentrations of Lp(a) and LDL cholesterol (apolipoprotein B) in serum are under separate metabolic control.This publication has 17 references indexed in Scilit:
- Lp(a) lipoprotein as a risk factor for myocardial infarctionJAMA, 1986
- Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a)Biochemistry and Cell Biology, 1986
- Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.Circulation, 1986
- Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarctionAtherosclerosis, 1986
- Levels of lipoprotein Lp(a) decline with neomycin and niacin treatmentAtherosclerosis, 1985
- Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a)Journal of Lipid Research, 1985
- Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozololBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Apolipoprotein E polymorphism and coronary artery disease.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- Lipoprotein Lp(a) and the risk for myocardial infarctionAtherosclerosis, 1981
- Radioimmunoassay of human plasma Lp(a) lipoproteinJournal of Lipid Research, 1977